Algert Global LLC Sorrento Therapeutics, Inc. Transaction History

Algert Global LLC

  • $3.72 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.0 - $4.9 $40,366 - $98,896
-20,183 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$4.65 - $7.23 $1,767 - $2,747
380 Added 1.92%
20,183 $94,000
Q3 2021

Nov 15, 2021
BUY
$7.41 - $10.99 $146,740 - $217,634
19,803 New
19,803 $151,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email